Faecal immunochemical tests for haemoglobin: Analytical challenges and potential solutions

被引:25
作者
Benton, Sally C. [1 ]
Symonds, Erin [2 ,3 ]
Djedovic, Natasha [4 ]
Jones, Samantha [5 ]
Deprez, Liesbet [6 ]
Kocna, Petr [7 ,8 ]
Auge, Josep Maria [9 ]
机构
[1] Royal Surrey Cty Hosp, NHS Bowel Canc Screening South England Hub, Berkshire & Surrey Pathol Serv, Clin Biochem, Guildford, Surrey, England
[2] Flinders Med Ctr, Bowel Hlth Serv, Bedford Pk, SA, Australia
[3] Flinders Univ S Australia, Canc Res, Flinders Hlth & Med Res, Bedford Pk, SA, Australia
[4] London North West Univ Healthcare NHS Trust, NHS Bowel Canc Screening London Hub, Clin Biochem, London, England
[5] Cardiff & Vale Univ Hlth Board, Weqas, Cardiff, Wales
[6] European Commiss, Joint Res Ctr JRC, Geel, Belgium
[7] Charles Univ Prague, Med Fac 1, Lab Gastroenterol, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic
[8] Gen Univ Hosp, Prague, Czech Republic
[9] Hosp Clin Barcelona, Clin Chem & Mol Genet Dept, Barcelona, Catalonia, Spain
关键词
Faecal Immunochemical Test; FIT; Colorectal cancer; Cancer screening; Bowel cancer; Haemoglobin; Harmonisation; Pre-analytical; External quality assurance; Internal quality assurance; WORKING GROUP RECOMMENDATIONS; COLORECTAL-CANCER; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; NEED;
D O I
10.1016/j.cca.2021.01.024
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Quantitative faecal immunochemical tests for haemoglobin (FIT) are being used increasingly around the world in colorectal cancer screening programmes, and in patients presenting with lower bowel symptoms to determine who should proceed to further bowel visualisation investigations, usually colonoscopy. The clinical utility of FIT is well reported. There are a number of analytical challenges including pre-analytical variation, difficulty setting up external quality assessment schemes, access to third party internal quality control material and a lack of standardisation or harmonisation of FIT methods. Here we report the work of the International Federation of Clinical Chemistry FIT Working Group. We provide an overview of the main pre-analytical variables; discuss different approaches to external quality assurance of FIT; propose a solution to third party internal quality assurance materials and summarise the challenges of standardisation and harmonisation of FIT.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 54 条
  • [1] Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed
    Allison, James E.
    Fraser, Callum G.
    Halloran, Stephen P.
    Young, Graeme P.
    [J]. GASTROENTEROLOGY, 2012, 142 (03) : 422 - 424
  • [2] Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
    Amitay, Efrat L.
    Gies, Anton
    Weigl, Korbinian
    Brenner, Hermann
    [J]. CANCERS, 2019, 11 (03):
  • [3] British Society of Gastroenterology, 2020, ADV REG WORK END VUL
  • [4] Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests
    Brown, Louise F.
    Fraser, Callum G.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 604 - 605
  • [5] Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin
    Buron, Andrea
    Macia, Francesc
    Andreu, Montserrat
    Pellise, Maria
    Castells, Xavier
    Grau, Jaume
    [J]. MEDICINA CLINICA, 2019, 152 (08): : 303 - 306
  • [6] An assessment of the effect of haemoglobin variants on detection by faecal immunochemical tests
    Carroll, Magdalen R. R.
    John, Cerin
    Mantio, Debbie
    Djedovic, Natasha K.
    Benton, Sally C.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2018, 55 (06) : 706 - 709
  • [7] Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer
    Chapman, Caroline J.
    Banerjea, Ayan
    Humes, David J.
    Allen, Jaren
    Oliver, Simon
    Ford, Abby
    Hardy, Katie
    Djedovic, Natasha
    Logan, Richard F.
    Morling, Joanne R.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (04) : 721 - 728
  • [8] Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort
    Chen, Li-Sheng
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Liao, Chao-Sheng
    Chen, Hsiu-Hsi
    [J]. LANCET ONCOLOGY, 2011, 12 (06) : 551 - 558
  • [9] Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
    Chiu, Han-Mo
    Chen, Sam Li-Sheng
    Yen, Amy Ming-Fang
    Chiu, Sherry Yueh-Hsia
    Fann, Jean Ching-Yuan
    Lee, Yi-Chia
    Pan, Shin-Liang
    Wu, Ming-Shiang
    Liao, Chao-Sheng
    Chen, Hsiu-Hsi
    Koong, Shin-Lan
    Chiou, Shu-Ti
    [J]. CANCER, 2015, 121 (18) : 3221 - 3229
  • [10] Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby, Jayne
    Cleary, Shirley
    Gray, Lynne
    Datt, Pooja
    Goudie, David R.
    Steele, Robert J. C.
    Strachan, Judith A.
    Humphries, Adam
    Fraser, Callum G.
    Mowat, Craig
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (05) : 559 - 566